Related Posts
NSE takes fresh IPO plan to Sebi, 3rd time in 8 years
NSE, the largest stock exchange in India, is making a fresh attempt to list on the stock market following an eight-year delay due to regulatory […]
At Rs 58 crore, cancer drug emerges top seller among new launches in 2024
- staff
- February 16, 2025
- 0
Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3,100 new brands collectively […]
NTPC Green IPO subscribed 93% on second day of offer
NTPC Green’s IPO, priced at Rs 102-108 per share, saw a 93% subscription on its second day. Retail investors showed strong interest with 2.38 times […]